Interaction of ibuprofen and probenecid with drug metabolizing enzyme phenotyping procedures using caffeine as the probe drug
Open Access
- 11 February 2003
- journal article
- Published by Wiley
- Vol. 55 (2) , 191-198
- https://doi.org/10.1046/j.1365-2125.2003.01725.x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Molecular Aspects of Renal Anionic Drug TransportAnnual Review of Physiology, 2002
- Isolation of a Family of Organic Anion Transporters from Human Liver and KidneyBiochemical and Biophysical Research Communications, 2001
- Cellular and molecular aspects of drug transport in the kidneyKidney International, 2000
- ARYLAMINEN-ACETYLTRANSFERASE ACTIVITY IN MANDrug Metabolism Reviews, 1999
- Clinical Pharmacokinetics of IbuprofenClinical Pharmacokinetics, 1998
- Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic InteractionsClinical Pharmacokinetics, 1997
- Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) genePharmacogenetics, 1994
- Pharmacogenetic Phenotyping and GenotypingClinical Pharmacokinetics, 1994
- N-acetyltransferase polymorphism: Comparison of phenotype and genotype in humansBiochemical Pharmacology, 1991
- Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.Journal of Clinical Investigation, 1990